This content is from: Features

Finding a middle ground

Edward Kelly and Franck Fougère debate the merits of Thailand’s programme of compulsory licensing for pharmaceutical patents.

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial

Related